» Articles » PMID: 9809962

Increased Left Ventricular Mass and Hypertrophy Are Associated with Increased Risk for Sudden Death

Overview
Date 1998 Nov 11
PMID 9809962
Citations 245
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study examined the relations of echocardiographically determined left ventricular (LV) mass and hypertrophy to the risk of sudden death.

Background: Echocardiographic LV hypertrophy is associated with increased risk for all-cause mortality and cardiovascular disease morbidity and mortality. However, little is known about the association of echocardiographic LV hypertrophy with sudden death.

Methods: We examined the relations of LV mass and hypertrophy to the incidence of sudden death in 3,661 subjects enrolled in the Framingham Heart Study who were > or =40 years of age. The baseline examination was performed from 1979 to 1983 and LV hypertrophy was defined as LV mass (adjusted for height) > 143 g/m in men and > 102 g/m in women. During up to 14 years of follow-up there were 60 sudden deaths. Cox models examined the relations of LV mass and LV hypertrophy to sudden death risk after adjusting for known risk factors.

Results: The prevalence of LV hypertrophy was 21.5%. The risk factor-adjusted hazard ratio (HR) for sudden death was 1.45 (95% confidence interval [CI] 1.10 to 1.92, p=0.008) for each 50-g/m increment in LV mass. For LV hypertrophy, the risk factor-adjusted HR for sudden death was 2.16 (95% CI 1.22 to 3.81, p=0.008). After excluding the first 4 years of follow-up, both increased LV mass and LV hypertrophy conferred long-term risk of sudden death (HR 1.53, 95% CI 1.01 to 2.28, p=0.047 and HR 3.28, 95% CI 1.58 to 6.83, p=0.002, respectively).

Conclusions: Increased LV mass and hypertrophy are associated with increased risk for sudden death after accounting for known risk factors.

Citing Articles

Diagnosis and Management of Hypertensive Heart Disease: Incorporating 2023 European Society of Hypertension and 2024 European Society of Cardiology Guideline Updates.

Wang B J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997480 PMC: 11856785. DOI: 10.3390/jcdd12020046.


Sex and Gender Differences in Ventricular Arrhythmias.

Warnock R, Modi R, Westerman S US Cardiol. 2024; 17:e12.

PMID: 39559519 PMC: 11571389. DOI: 10.15420/usc.2022.38.


AI-based cluster analysis enables outcomes prediction among patients with increased LVM.

Loutati R, Kolben Y, Luria D, Amir O, Biton Y Front Cardiovasc Med. 2024; 11:1357305.

PMID: 39285853 PMC: 11402694. DOI: 10.3389/fcvm.2024.1357305.


Comparison of left ventricular mass and wall thickness between cardiac computed tomography angiography and cardiac magnetic resonance imaging using machine learning algorithms.

van Driest F, van der Geest R, Omara S, Broersen A, Dijkstra J, Jukema J Eur Heart J Imaging Methods Pract. 2024; 2(3):qyae069.

PMID: 39224625 PMC: 11367951. DOI: 10.1093/ehjimp/qyae069.


Piezo1 is the cardiac mechanosensor that initiates the cardiomyocyte hypertrophic response to pressure overload in adult mice.

Yu Z, Gong H, Kesteven S, Guo Y, Wu J, Li J Nat Cardiovasc Res. 2024; 1(6):577-591.

PMID: 39195867 PMC: 11358016. DOI: 10.1038/s44161-022-00082-0.